Related Experiment Video
Updated: Feb 15, 2026
07:09
Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
13.7K
[Volume reduction surgery--a new treatment concept in advanced diffuse pulmonary emphysema]
1Klinik für Viszeralchirurgie, Universitätsspital Zürich.
Schweizerische Medizinische Wochenschrift
|November 11, 1995
Summary
Bilateral thoracoscopic volume reduction surgery offers significant improvements in pulmonary function and exercise capacity for patients with advanced, diffuse emphysema. This palliative procedure showed no perioperative mortality in over 20 patients.
Area of Science:
- Pulmonology
- Thoracic Surgery
- Emphysema Treatment
Context:
- Emphysema management often involves surgical interventions.
- Large bullae excision is suitable for localized disease.
- Diffuse emphysema requires different surgical approaches like volume reduction.
Purpose:
- To prospectively evaluate bilateral thoracoscopic lung volume reduction surgery.
- To assess the efficacy of this procedure for advanced, diffuse emphysema.
Summary:
- Over 20 patients with advanced, diffuse emphysema underwent bilateral thoracoscopic volume reduction.
- Preoperative FEV1 averaged 765 ml/sec, improving by 40% within 3 months.
- 12-minute walking distance improved by over 100% with no perioperative mortality.
Impact:
- Demonstrates significant improvement in pulmonary function and exercise capacity.
- Highlights the palliative benefits of this surgical approach.
- Offers a viable option for select patients with severe emphysema.
Related Concept Videos
01:12Diffusion
222.3K
Diffusion is the passive movement of substances down their concentration gradients—requiring no expenditure of cellular energy. Substances, such as molecules or ions, diffuse from an area of high concentration to an area of low concentration in the cytosol or across membranes. Eventually, the concentration will even out, with the substance moving randomly but causing no net change in concentration. Such a state is called dynamic equilibrium, which is essential for maintaining overall...
222.3K
01:21Diffusion
6.7K
Diffusion is a type of passive transport. In passive transport, a substance tends to move from an area of high concentration to an area of low concentration until the concentration is equal across the space. For example, take the diffusion of substances through the air. When someone opens a perfume bottle in a room filled with people, the perfume is at its highest concentration in the bottle and is at its lowest at the edges of the room. The perfume vapor will diffuse, or spread away, from the...
6.7K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
630
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
630
01:19Self-Concept
1.7K
Self-concept is the cognitive and emotional understanding individuals hold about their identity. It evolves through various developmental stages, beginning in infancy and maturing as children grow. This concept influences how individuals perceive their abilities, interact with others, and manage challenges throughout life.
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
Infancy and Emerging Recognition
During infancy, self-concept is virtually nonexistent. Babies do not distinguish themselves as separate entities and often mistake their...
1.7K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
489
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
489
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
527
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
527